Adjuvant vaginal high-dose-rate afterloading alone in endometrial carcinoma: Patterns of relapse and side effects following low-dose therapy

Gynecologic Oncology

Volumn 71, Issue 1, 1998, Pages 72-76

  Weiss, Elisabeth ^a   Hirnle, Peter ^b   Arnold Bofinger, Heike ^b   Hess, Clemens F ^a   Bamberg, Michael ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; DRUG MEGADOSE; ENDOMETRIUM CARCINOMA; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION DOSE; RELAPSE; RETROSPECTIVE STUDY;

EID: 0032190688     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.5155     Document Type: Article

References (24)

1. Aalders J, Abeler V, Kolstad P, Onsrud M. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: Clinical and histopathological study of 540 patients. Obstet Gynecol. 56:1980;419-427.
2. Kucera H, Vavra N, Weghaupt K. Benefit of external irradiation in pathologic stage I endometrial carcinoma: A prospective clinical trial of 605 patients who received postoperative vaginal irradiation and additional pelvic irradiation in the presence of unfavorable prognostic factors. Gynecol Oncol. 38:1990;99-104.
3. Morrow C P, Bundy B N, Kurman R J, Creasman W T, Heller P, Homesley H D, Graham J E. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group Study. Gynecol Oncol. 40:1991;55-65.
4. Eltabbakh G H, Piver M St, Hempling R E, Shin K H. Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: Report of a prospective trial. Int J Radiat Oncol Biol Phys. 38:1997;373-380.
5. Greven K M, Corn B W, Case D, Purser Ph, Lanciano R M. Which prognostic factors influence the outcome of patients with surgically staged endometrial cancer treated with adjuvant radiation? Int J Radiat Oncol Biol Phys. 39:1997;413-418.
6. Grigsby P W, Perez C A, Kuten A, Simpson J R, Garcia D M, Camel H M, Kao M S, Galakatos A E. Clinical stage I endometrial cancer: Prognostic factors for local and distant metastasis and implications of the new FIGO surgical staging system. Int J Radiat Oncol Biol Phys. 22:1992;905-911.
7. Nori D, Merimsky O, Batata M, Caputo Th. Postoperative high dose-rate intravaginal brachytherapy combined with external irradiation for early stage endometrial cancer: A long-term follow-up. Int J Radiat Oncol Biol Phys. 30:1994;831-837.
8. Kucera H. Value and indication of radiotherapy in the endometrial carcinoma. Strahlenther Onkol. 167:1991;381-386.
9. Noyes W R, Bastin K, Edwards S A, Buchler D A, Stitt J A, Thomadsen B R, Fowler J F, Kinsella T. Postoperative vaginal cuff irradiation using high dose rate remote afterloading: A phase II clinical protocol. Int J Radiat Oncol Biol Phys. 32:1995;1439-1443.
10. Park R C, Grigsby P W, Muss H B, Norris H J. Corpus: Epithelial Tumors. Principles and Practice of Gynecological Oncology. 1992;Lippincott, Philadelphia. p. 663-693.
11. FIGO. Annual report on the results of treatment in gynecological cancer. Int J Gynecol Obstet. 28:1989;189-193.
12. Chassagne D, Sismondi P, Horiot J C, Sinistrero G, Bey P, Zola P, Pernot M, Gerbaulet A, Kunkler I, Michel G. A glossary for reporting complications of treatment in gynecological cancers. Radiother Oncol. 26:1993;195-202.
13. Kloetzer K-H, Günther R, Wendt T. Die Vaginalstumpf-Rezidivrate beim Endometriumkarzinom in Abhängigkeit des Zielvolumens der postoperativen HDR-Afterloading-Brachyherapie. Strahlenther Onkol. 173:1997;13-17.
14. Sorbe B G, Smeds A-Ch. Postoperative vaginal irradiation with high dose rate afterloading technique in endometrial carcinoma stage I. Int J Radiat Oncol Biol Phys. 19:1990;305-314.
15. 192. Int J Radiat Oncol Biol Phys. 40:1998;77-84.
16. Gumbs A A, Turner B C, Knisely J PS, Kacinski B M, Roberts K B, Peschel R E, Haffty B G, Rutherford T J, Edraki B, Schwartz P E, Wilson L D. Post-operative high dose rate vaginal apex brachytherapy in stage I endometrial adenocarcinoma. Int J Radiat Oncol Biol Phys. 36:1996;327.
17. De Palo G, Mangioni C, Periti P, Del Vecchio, M Marubini E. Treatment of FIGO (1971) stage I endometrial carcinoma with intensive surgery, radiotherapy and hormonotherapy according to pathological prognostic groups: Longterm results of a randomized multicentre study. Eur J Cancer. 29A:1993;1133-1140.
18. Bedwinek J, Galakatos A, Camel M, Kao M-S, Stokes S, Perez C. Stage I, grade III adenocarcinoma of the endometrium treated with surgery and irradiation. Cancer. 54:1984;40-47.
19. Reisinger S A, Staros E B, Mohiuddin M. Survival and failure analysis in stage II endometrial cancer using the revised 1988 FIGO staging system. Int J Radiat Oncol Biol Phys. 21:1991;1027-1032.
20. ICRU, Dose and volume specification for reporting intracavitary therapy in gynecology, Bethesda, MD, International Commission on Radiation Units and Measurements, 1985, Report 38.
21. Weiss E, Arnold-Bofinger H, Hirnle P. Radiation therapy alone in the treatment of endometrial carcinoma. Zentralbl Gynakol. 117:1995;481-485.
22. Kapp K S, Stuecklschweiger G F, Kapp D S, Hackl A G. Dosimetry of intracavitary placements for uterine and cervical carcinoma: Results of orthogonal film, TLD, and CT-assisted techniques. Radiother Oncol. 24:1992;137-146.
23. Schoepel S L, LaVigne M L, Martel M K, McShan D L, Fraass B A, Roberts J A. Three-dimensional treatment planning of intracavitary gynecologic implants: Analysis of ten cases and implications for dose specification. Int J Radiat Oncol Biol Phys. 28:1993;277-283.
24. Weiss E, Pradier O, Laurent D, Hess C F. CT-based treatment planning in gynecological HDR-brachytherapy: Questions on PTV and tolerance dose in organs at risk. Radiother Oncol. 47:1998;S7.